key: cord-1046637-01qc7ju6 authors: Zubarioglu, Tanyel; Hopurcuoglu, Duhan; Ahmadzada, Saffa; Uzunyayla‐Inci, Gözde; Cansever, Mehmet Serif; Kiykim, Ertugrul; Aktuglu‐Zeybek, Cigdem title: Inborn errors of metabolism and COVID‐19: Evaluation of the metabolic outcome date: 2021-07-30 journal: Pediatr Int DOI: 10.1111/ped.14938 sha: 5565bb106170b7d05fcb39d0c226583350419847 doc_id: 1046637 cord_uid: 01qc7ju6 BACKGROUND: Infectious diseases can result a catabolic state and possibly trigger an acute metabolic decompensation in inborn errors of metabolism (IEM) that will even be life threatening. Studies regarding the course of SARS‐CoV‐2 infections in patients with IEM are generally limited to case reports. Here, we aimed to evaluate the clinical findings of COVID‐19 and describe the impact of SARS‐CoV‐2 infections on metabolic outcome in IEM patients. METHODS: Patients who were diagnosed as different types of IEM and developed microbiologically confirmed COVID‐19 infection were included. Clinical findings and laboratory results were recorded retrospectively in terms of both IEM and COVID‐19. RESULTS: Eleven patients with diagnosis of intoxication type metabolic disorders, five patients with energy metabolism disorders and six patients with complex molecular disorders were enrolled. The most frequent clinical finding was fever (52.1%) followed by fatigue/myalgia (47.8%). None of the patients was younger than 1 years of old. None of the patients presented severe or critical disease. In terms of metabolic decompensation, two patients diagnosed with propionic acidemia, one patient with methylmalonic acidemia and one patient with 3‐hydroxy‐3‐methylglutaryl‐CoA lyase deficiency presented clinical and biochemical findings of an acute metabolic attack. CONCLUSIONS: Based on our results, IEM are not found to be an additional risk factor for severe COVID‐19 infection. However, patients with ‐ particularly intoxication type and energy metabolism disorders‐should be considered as a vulnerable population for COVID‐19 and have a major risk of developing acute metabolic decompensation that can lead to life threatening complications. metabolism pathway (inborn errors of amino acid metabolism, urea cycle disorders, sugar intolerances, etc.) (2) energy metabolism disorders are caused by defective production or utilization of the energy and consist both cytoplasmic and mitochondrial metabolism disorders (3) complex molecular disorders mainly include disorders of cellular organelles that disturb the synthesis, remodeling, recycling, trafficking and catabolism of complex molecules. Infectious diseases in IEM can result in an increase in catabolism and possibly trigger an acute metabolic decompensation that will even be life threatening. 1 The Coronavirus Disease-19 (COVID-19) that is caused by SARS-CoV-2 was declared as a global health emergency and then announced as a pandemic worldwide by the World Health Organization (WHO) in March 2020. According to WHO COVID-19 database, 142.557.268 confirmed cases including 3.037.398 deaths were reported until 21 April 2021. 2 As all age groups are found susceptible to COVID-19, studies concerning COVID-19 in pediatric patients aged from neonate to late adolescents have been described in literature from the first announcement of the disease in detail. The clinical severity of COVID-19 can vary widely in pediatric patients, from asymptomatic disease to multisystemic involvement, especially in patients with underlying comorbidity and immunosuppression. Frequent clinical findings can be listed as fever, cough, sore throat, malaise, myalgia, dyspnea, headache, nasal discharge, and gastrointestinal symptoms in children. [3] [4] [5] Most recently, multisystem inflammatory syndrome in children (MIS-C) was described as characterized by laboratory and clinical evidence of inflammation with multisystemic organ involvement within the four weeks of COVID-19. 6 This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved dysfunction, including encephalopathy, myocardial injury, coagulation abnormalities, and acute kidney injury. 3 All procedures followed were in accordance with the ethical standards of the local Ethical Committee of Cerrahpasa Medical Faculty and with the Helsinki Declaration of 1975, as revised in 2013. All parents of the patients included in the present study gave informed consent. Patients were divided into three subgroups according to the type of IEM in terms of main This article is protected by copyright. All rights reserved Fever and cough were reported as the most frequent symptoms relevant to COVID-19 in children followed by fatigue/malaise, sore throat, muscle pain, headache, dyspnea and gastrointestinal symptoms in different studies. 5, 16, 17 Pediatric aged patients were generally found to be prone to have a milder course of disease, most of the patients were asymptomatic or presented mild/moderate disease. In one of the largest pediatric series, only 5.9 % among 728 confirmed and 1407 probable COVID-19 infected patients were found to be severe and/or critically ill. 3 However, clinical severity varies and different ratios have been reported. In a study from Turkey, the percentage of severe and/or critically ill patients was reported to be 27.1% among 37 confirmed pediatric COVID-19 patients and ten patients (27%) required PICU admission. 17 Authors state no conflict of interest. This article is protected by copyright. All rights reserved All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. TZ serves as the guarantor for the article. She accepts full responsibility for the work, had access to the data and controlled the decision to publish. She has been involved in conception, design, analysis and interpretation of the data and also drafting the article. DH, SA and GUI have been involved in conception, design, analysis and interpretation of the data. MSC and EK have been involved in analysis and interpretation of the data. CAZ has been involved in conception, design, interpretation of the data and revising the article critically for important intellectual content. Urine ketones 3(+) 2(+) 3(+) Ø This article is protected by copyright. All rights reserved Clinical approach to inborn errors of metabolism in pediatrics Epidemiology of COVID-19 Among Children in China SARS-CoV-2 infection in children Characteristics and Management of Children with COVID-19 in Turkey A recently explored aspect of the iceberg named COVID-19:multisystem inflammatory syndrome in children (MIS-C) Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease Gaucher disease and SARS-CoV-2 infection: Emerging management challenges The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective Challenges of following patients with inherited metabolic diseases during the COVID-19 outbreak. A cross-sectional online survey study Fatal COVID-19 infection in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A case report SARS-CoV-2 infection in a patient with propionic acidemia Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review Accepted Article